Harvard MD: The Truth About Peptides And Longevity Medicine

Harvard MD: The Truth About Peptides And Longevity Medicine

Harvard MD: The Peptide Boom Is Here.. But Is Medicine Ready? In this episode of Return on Health, Niko and Miguel speak with Dr. Anand Vinjamoori, Harvard Medical School and Harvard Business School trained physician, former founding Chief Medical Officer at Modern Age, advisor to Superpower, and founder of Next Generation Medicine. Together, they discuss why longevity medicine is booming while many companies still struggle to build sustainable businesses, why peptides may become one of the next major waves in health optimization, and why the future of biomarkers will likely require a much more individualized and data-driven approach. This episode covers: The peptide boom and why it matters Why longevity businesses often fail What biomarkers can and cannot tell us Dr. Anand explains why the current medical evidence system may be too slow for the next generation of therapies, how real-world data and patient registries could help close the evidence gap, and why biomarkers should be used with nuance rather than treated as absolute truth. He also shares his view on overhyped interventions, the role of exercise, and the cultural differences between American optimization culture and European lifestyle rhythms. Key topics Longevity medicine and market timing The business challenges behind longevity clinics Customer acquisition and why messaging matters The rise of peptides in health optimization Evidence gaps, real-world data, and patient registries Personalized medicine and individual risk assessment Biomarkers, multi-omics, and biological individuality Why HBA1c can be overinterpreted Exercise as one of the strongest health interventions Cold plunges and the problem of overapplied hormesis European lifestyle culture vs. American optimization culture Chapters 00:00 The Longevity Paradox 01:03 Building Modern Age and the Early Longevity Market 05:04 Personal Motivations Behind Longevity Medicine 07:57 What Patients Actually Want From Longevity Care 11:39 Why Many Longevity Businesses Struggle 15:12 How Customer Preferences Have Changed 18:21 Peptides as the Next Big Wave 19:07 Peptides, Regulation, and Medical Experimentation 24:24 The Evidence Gap in Peptide Use 30:58 Why Medicine Needs Better Risk Assessment 36:59 Biomarkers and Biological Ground Truth 44:20 Multi-Omics and the Future of Measurement 48:35 Which Biomarkers Are Useful — And Which Are Noise? 52:42 Culture, Lifestyle, and Health Optimization 55:45 Lightning Round: Metrics, Interventions, and Healthcare Reform Guest Dr. Anand VinjamooriHarvard Medical School and Harvard Business School trained physician, former founding Chief Medical Officer at Modern Age, advisor to Superpower, and founder of Next Generation Medicine. Guest links LinkedIn: https://www.linkedin.com/in/vinjamoori/ [https://www.linkedin.com/in/vinjamoori/] Next Generation Medicine: https://www.nextgenerationmedicine.co/ [https://www.nextgenerationmedicine.co/] Superpower: https://www.linkedin.com/company/superpower/posts/?feedView=all [https://www.linkedin.com/company/superpower/posts/?feedView=all] Listen now Return on Health is available wherever you get your podcasts. If you enjoyed this episode, leaving a 5-star rating on Spotify helps us bring more honest conversations about health, longevity, and medicine to more people.

Geriatrician: Most Aging Is Preventable (But We Start Too Late)

Most people think aging is something that happens later. In reality, the processes that determine how you age — and whether you stay functional — start decades earlier. In this episode of Return on Health, we sit down with Roberta Vella Azzopardi, a geriatrician and geroscientist with a PhD in cognitive frailty, to break down what aging actually looks like in clinical practice. Instead of focusing on single diseases, this conversation zooms out: Why do people lose independence? What really drives decline? And where are the biggest missed opportunities in prevention? What this episode covers * Why modern medicine often intervenes too late * What frailty really means — and why it matters more than age * How loss of muscle drives metabolic and cognitive decline * The concept of peak span and why function beats lifespan * Why hearing loss is one of the biggest overlooked dementia risk factors * The massive gap in menopause and women’s health care * What actually works vs. what’s just hype in longevity Key takeaways Frailty is best understood as loss of physiological reserves. When those reserves drop below a certain threshold, even small stressors can lead to long-term decline. This is why two people at the same age can look completely different clinically — one independent, one dependent. A major driver of this process is muscle loss. Muscle is not just about movement. It directly affects metabolic health, insulin sensitivity, and even brain function. The good news: even later in life, resistance training and sufficient protein intake can still improve outcomes. One of the most underestimated risk factors discussed in this episode is hearing loss. It contributes to cognitive decline through increased cognitive load, social isolation, and shared vascular mechanisms — yet remains widely underdiagnosed and undertreated. Another critical blind spot is women’s health, especially around menopause. Many symptoms are treated in isolation instead of addressing underlying hormonal changes, leading to years of missed intervention opportunities. Timestamps (00:00) Introduction & Roberta’s background (04:30) Frailty explained: vulnerability vs. age (11:00) Why prevention starts decades earlier (16:50) Reversing decline: muscle, protein, training (21:00) Peak span vs. lifespan (28:30) Menopause and missed diagnoses (36:30) Dementia prevention & modifiable risks (37:00) Hearing loss and cognitive decline (50:00) Busting common aging myths (55:00) Lightning round insights Takeaways * Start investing in your health early — not when problems appear * Maintain muscle mass through resistance training and protein intake * Don’t ignore hearing health — it directly impacts brain health * Look at root causes, not isolated symptoms * Prevention is not one intervention — it’s a system Roberta: https://www.linkedin.com/in/roberta-vella-azzopardi-md-phd-8235878a/ [https://www.linkedin.com/in/roberta-vella-azzopardi-md-phd-8235878a/] Return on Health: https://returnonhealth.de/ [https://returnonhealth.de/] Niko: https://www.linkedin.com/in/niko-hems/ [https://www.linkedin.com/in/niko-hems/] https://www.instagram.com/niko_hems [https://www.instagram.com/niko_hems] https://nikohems.de/ [https://nikohems.de/] Miguel: https://www.linkedin.com/in/miguel-medina-stanivukovic-857b9720b/ [https://www.linkedin.com/in/miguel-medina-stanivukovic-857b9720b/] https://www.instagram.com/miguelmedinastanivukovic/?hl=en [https://www.instagram.com/miguelmedinastanivukovic/?hl=en]

Karolinska MD PhD: The Hidden Phase Before Disease

Karolinska MD PhD: You Feel Healthy. Your Data Disagrees Most people think they’re healthy. But biology doesn’t care how you feel. Long before symptoms show up, your physiology is already shifting.. and most check-ups won’t catch it. In this episode, we sit down with Natalia Trpchevska (MD, PhD Karolinska, Medical & Scientific Director at AYUN) to break down what longevity medicine actually looks like when applied properly. We go beyond surface-level optimization and talk about what actually drives risk: mitochondria, metabolic flexibility, genetics, and why most people are already off track without knowing it. This episode covers: * Why longevity medicine still struggles in practice * Mitochondria, NAD+ and optimization myths * Biohacking and the future of healthcare Key takeaways: * Health declines silently — symptoms come late * Longevity medicine asks: where are you heading biologically? * The basics still dominate outcomes — most people underestimate them * The next level is personalization, not more hacks * Two “healthy” people can have completely different risks * Mitochondria adapt first — then they start driving dysfunction * Most mitochondrial interventions are misunderstood * Genetics gives probabilities, not certainty * Real optimization = prioritization + sequencing About Natalia: Natalia Trpchevska is a medical doctor and holds a PhD in genetics from the Karolinska Institutet. She is the Medical & Scientific Director at AYUN in Zurich, where she focuses on applying systems biology and layered diagnostics to detect early shifts in physiology — before disease develops. Her work bridges clinical medicine and research, with a strong emphasis on translating complex biology into actionable interventions. Timestamps: 00:00 – Introduction & Natalia’s background (Karolinska, genetics → clinic) 03:30 – Why genetics naturally leads into longevity medicine 05:00 – What longevity medicine actually does differently 07:30 – “Physiology before pathology” explained 09:30 – The basics vs. the real next level 11:30 – Same lifestyle, completely different risk profiles 13:30 – APOE4, Lp(a) and personalized strategy 15:00 – Mitochondria: what actually happens as you age 18:30 – When mitochondrial dysfunction becomes clinically relevant 21:00 – Cause vs. consequence: where mitochondria fit in aging 23:30 – How mitochondrial function is actually measured 26:30 – Why isolated tests don’t work (layered diagnostics) 29:00 – What happens after testing: prioritization & sequencing 32:00 – Why “doing everything” doesn’t work 35:00 – IHHT explained: mechanism, benefits, limitations 38:30 – Risks, contraindications & when it backfires 41:00 – Environment vs. lifestyle: what really drives dysfunction 44:00 – The hierarchy: metabolism → inflammation → toxins 47:00 – Why most people focus on the wrong layer 49:30 – What genetics got wrong over the last decade 53:00 – Polygenic risk, probabilities & real-world use 56:00 – Gene–environment interaction: what actually matters 58:30 – Final thoughts: what people still misunderstand about health Links: Natalia: https://www.linkedin.com/in/natalia-trpchevska/ [https://www.linkedin.com/in/natalia-trpchevska/] https://www.ayun.ch/ [https://www.ayun.ch/] More about Return on Health: https://returnonhealth.de/ [https://returnonhealth.de/] Niko: https://www.linkedin.com/in/niko-hems/ [https://www.linkedin.com/in/niko-hems/] https://www.instagram.com/niko_hems [https://www.instagram.com/niko_hems] https://nikohems.de/ [https://nikohems.de/] Miguel: https://www.linkedin.com/in/miguel-medina-stanivukovic-857b9720b/ [https://www.linkedin.com/in/miguel-medina-stanivukovic-857b9720b/] https://www.instagram.com/miguelmedinastanivukovic/ [https://www.instagram.com/miguelmedinastanivukovic/]

Medical Doctor: Primary Care Is Broken!

Rethinking Primary Care and Longevity: Insights with Dr. Takhar. In this episode, Dr. Takhar, UCLA and Harvard trained physician-scientist shares his journey from emergency and internal medicine to building a groundbreaking primary care model focused on human connection, longer physician-patient times, and personalized longevity strategies. We explore how systemic issues hinder patient-centered care and what reforms could make healthcare more effective, preventative, and humane. Key topics: * The limitations of conventional healthcare: burnout, bureaucracy, short visits * The unique model of Primary MD: small panels, extensive diagnostics, longer consultations * Human connection as a pillar of effective medicine * The importance of listening and communication skills in healthcare * Ethical considerations of concierge medicine and access equity * The role of diagnostics: lipid panels, advanced markers, and their clinical relevance * Risks, hype, and evidence in emerging longevity interventions * Future pathways for systemic reform: data, evidence, insurance, and policy shifts * Lessons from infectious disease training applied to longevity and longevity safety * The "Mixed Medical Arts" approach: integrating diverse fields for optimal patient outcomes Timestamps: * (00:00) - Introduction to Dr. Takhar and the care collision in modern medicine * (02:07) - Clinical experiences shaping innovative primary care * (07:12) - The human component in healthcare and systemic barriers * (10:53) - What primary MD does differently to foster patient trust * (13:20) - Teaching patients the 'why' behind health decisions * (14:17) - The vital role of health coaches in adherence and engagement * (15:32) - The holistic approach combining diagnostics, trust, and relationship * (18:07) - Addressing ethics and access in concierge-like models * (19:36) - How to demonstrate value and scalable models * (22:37) - Overcoming telehealth technical issues in podcast interviews * (23:58) - The importance of comprehensive, integrated care strategies * (26:32) - Membership-based care: structure and patient experience * (27:33) - Ethical considerations of luxury care and future access * (36:36) - System change: from volume to value and prevention * (42:48) - Infectious disease background shaping longevity skepticism * (46:55) - The dangers of hype and unproven interventions * (50:32) - Bottom-up demand and the future of preventative medicine More about Return on Health: https://returnonhealth.de/ [https://returnonhealth.de/] Dr. Sukhjit “Sarge” Takhar: https://www.linkedin.com/in/sukhjit-takhar-md/ [https://www.linkedin.com/in/sukhjit-takhar-md/?utm_source=chatgpt.com] https://www.primary-md.com/ [https://www.primary-md.com/?utm_source=chatgpt.com] Niko: https://www.linkedin.com/in/niko-hems/ [https://www.linkedin.com/in/niko-hems/] https://www.instagram.com/niko_hems [https://www.instagram.com/niko_hems] https://nikohems.de/ [https://nikohems.de/] Miguel: https://www.linkedin.com/in/miguel-medina-stanivukovic-857b9720b/ https://www.instagram.com/miguelmedinastanivukovic/?hl=en This episode underscores the critical need for systems that prioritize genuine human connection, personalized diagnostics, and thoughtful health promotion to advance longevity and overall well-being.

Stanford MD: The Longevity Industry Is Lying To You

Longevity science is advancing quickly. Healthcare systems are moving much slower. In this episode, Stanford-trained physician Dr. Hillary Lin explains why prevention, biological age testing, mitochondria, and health optimization often struggle to translate into real clinical practice. We discuss the limits of NAD+ supplementation, the risks around peptides, and why behavioral change still drives most health outcomes. The conversation also looks at decentralizing healthcare, continuous monitoring, and why many high performers struggle with recovery despite doing “everything right.” What you’ll learn • Why longevity science and healthcare are misaligned • The role mitochondria play in aging and energy • When NAD+ supplementation can backfire • Risks around peptides and self-experimentation • Why behavior change drives most longevity gains • The future of continuous health monitoring Topics 00:00 The gap in longevity care 02:17 Hillary Lin’s path into longevity medicine 05:28 Decentralizing healthcare 08:13 Mental health navigation 14:05 Mitochondria and mitophagy 16:45 The NAD+ problem 22:33 High performer bottlenecks 27:20 Behavior change and longevity 30:31 Peptides in longevity medicine 35:02 Continuous healthcare models 46:19 Biological age testing 51:32 The future of healthcare monitoring Follow Hillary: https://www.hillarylinmd.com/ https://www.linkedin.com/in/hillarylinmd/ https://www.instagram.com/hillarylinmd/?hl=en More about Return on Health: ⁠https://returnonhealth.de/⁠ [https://returnonhealth.de/] Niko: ⁠https://www.linkedin.com/in/niko-hems/⁠ [https://www.linkedin.com/in/niko-hems/] ⁠https://www.instagram.com/niko_hems⁠ [https://www.instagram.com/niko_hems] ⁠https://nikohems.de/⁠ [https://nikohems.de/] Miguel: ⁠https://www.linkedin.com/in/miguel-medina-stanivukovic-857b9720b/⁠ [https://www.linkedin.com/in/miguel-medina-stanivukovic-857b9720b/] ⁠https://www.instagram.com/miguelmedinastanivukovic/?hl=en [https://www.instagram.com/miguelmedinastanivukovic/?hl=en]